BACKGROUND: Measles, a vaccine-preventable disease that can cause severe complications, was declared eliminated from the United States in 2000. The last published summary of US measles epidemiology was during 2001-2008. We summarized US measles epidemiology during 2009-2014. METHODS: We compared demographic, vaccination, and virologic data on confirmed measles cases reported to the Centers for Disease Control and Prevention during January 1, 2009-December 31, 2014 and January 1, 2001-December 31, 2008. RESULTS: During 2009-2014, 1264 confirmed measles cases were reported in the United States, including 275 importations from 58 countries and 66 outbreaks. The annual median number of cases and outbreaks during this period was 130 (range, 55-667 cases) and 10 (range, 4-23 outbreaks), respectively, compared with an annual median of 56 cases (P = .08) and 4 outbreaks during 2001-2008 (P = .04). Among US-resident case-patients during 2009-2014, children aged 12-15 months had the highest measles incidence (65 cases; 8.3 cases/million person-years), and infants aged 6-11 months had the second highest incidence (86 cases; 7.3 cases/million person-years). During 2009-2014, 865 (74%) of 1173 US-resident case-patients were unvaccinated and 188 (16%) had unknown vaccination status; of 917 vaccine-eligible US-resident case-patients, 600 (65%) were reported as having philosophical or religious objections to vaccination. CONCLUSIONS: Although the United States has maintained measles elimination since 2000, measles outbreaks continue to occur globally, resulting in imported cases and potential spread. The annual median number of cases and outbreaks more than doubled during 2009-2014 compared with the earlier postelimination years. To maintain elimination, it will be necessary to maintain high 2-dose vaccination coverage, continue case-based surveillance, and monitor the patterns and rates of vaccine exemption. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: Measles, a vaccine-preventable disease that can cause severe complications, was declared eliminated from the United States in 2000. The last published summary of US measles epidemiology was during 2001-2008. We summarized US measles epidemiology during 2009-2014. METHODS: We compared demographic, vaccination, and virologic data on confirmed measles cases reported to the Centers for Disease Control and Prevention during January 1, 2009-December 31, 2014 and January 1, 2001-December 31, 2008. RESULTS: During 2009-2014, 1264 confirmed measles cases were reported in the United States, including 275 importations from 58 countries and 66 outbreaks. The annual median number of cases and outbreaks during this period was 130 (range, 55-667 cases) and 10 (range, 4-23 outbreaks), respectively, compared with an annual median of 56 cases (P = .08) and 4 outbreaks during 2001-2008 (P = .04). Among US-resident case-patients during 2009-2014, children aged 12-15 months had the highest measles incidence (65 cases; 8.3 cases/million person-years), and infants aged 6-11 months had the second highest incidence (86 cases; 7.3 cases/million person-years). During 2009-2014, 865 (74%) of 1173 US-resident case-patients were unvaccinated and 188 (16%) had unknown vaccination status; of 917 vaccine-eligible US-resident case-patients, 600 (65%) were reported as having philosophical or religious objections to vaccination. CONCLUSIONS: Although the United States has maintained measles elimination since 2000, measles outbreaks continue to occur globally, resulting in imported cases and potential spread. The annual median number of cases and outbreaks more than doubled during 2009-2014 compared with the earlier postelimination years. To maintain elimination, it will be necessary to maintain high 2-dose vaccination coverage, continue case-based surveillance, and monitor the patterns and rates of vaccine exemption. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Amy Parker Fiebelkorn; Susan B Redd; Kathleen Gallagher; Paul A Rota; Jennifer Rota; William Bellini; Jane Seward Journal: J Infect Dis Date: 2010-10-07 Impact factor: 5.226
Authors: Philip J Smith; Sharon G Humiston; Edgar K Marcuse; Zhen Zhao; Christina G Dorell; Cynthia Howes; Beth Hibbs Journal: Public Health Rep Date: 2011 Jul-Aug Impact factor: 2.792
Authors: Jennifer S Rota; Carole J Hickman; Sun Bae Sowers; Paul A Rota; Sara Mercader; William J Bellini Journal: J Infect Dis Date: 2011-07 Impact factor: 5.226
Authors: Paul A Rota; Kevin E Brown; Judith M Hübschen; Claude P Muller; Joseph Icenogle; Min-Hsin Chen; Bettina Bankamp; Julia R Kessler; David W Brown; William J Bellini; David Featherstone Journal: J Infect Dis Date: 2011-07 Impact factor: 5.226
Authors: Mark J Papania; Gregory S Wallace; Paul A Rota; Joseph P Icenogle; Amy Parker Fiebelkorn; Gregory L Armstrong; Susan E Reef; Susan B Redd; Emily S Abernathy; Albert E Barskey; Lijuan Hao; Huong Q McLean; Jennifer S Rota; William J Bellini; Jane F Seward Journal: JAMA Pediatr Date: 2014-02 Impact factor: 16.193
Authors: Sanny Y Chen; Shoana Anderson; Preeta K Kutty; Francelli Lugo; Michelle McDonald; Paul A Rota; Ismael R Ortega-Sanchez; Ken Komatsu; Gregory L Armstrong; Rebecca Sunenshine; Jane F Seward Journal: J Infect Dis Date: 2011-04-28 Impact factor: 5.226
Authors: Freddy Caldera; Elizabeth Ann Misch; Sumona Saha; Arnold Wald; Youqi Zhang; Jeffrey Hubers; Bryant Megna; Dana Ley; Mark Reichelderfer; Mary S Hayney Journal: Dig Dis Sci Date: 2018-10-13 Impact factor: 3.199
Authors: Emily P Hyle; Naomi F Fields; Amy Parker Fiebelkorn; Allison Taylor Walker; Paul Gastañaduy; Sowmya R Rao; Edward T Ryan; Regina C LaRocque; Rochelle P Walensky Journal: Clin Infect Dis Date: 2019-07-02 Impact factor: 9.079
Authors: Emily P Hyle; Sowmya R Rao; Audrey C Bangs; Paul Gastañaduy; Amy Parker Fiebelkorn; Stefan H F Hagmann; Allison Taylor Walker; Rochelle P Walensky; Edward T Ryan; Regina C LaRocque Journal: JAMA Pediatr Date: 2020-02-03 Impact factor: 16.193
Authors: Paul A Gastañaduy; Sebastian Funk; Prabasaj Paul; Lilith Tatham; Nicholas Fisher; Jeremy Budd; Brian Fowler; Sietske de Fijter; Mary DiOrio; Gregory S Wallace; Bryan Grenfell Journal: Am J Epidemiol Date: 2018-09-01 Impact factor: 4.897
Authors: Sun B Sowers; Jennifer S Rota; Carole J Hickman; Sara Mercader; Susan Redd; Rebecca J McNall; Nobia Williams; Marcia McGrew; M Laura Walls; Paul A Rota; William J Bellini Journal: Clin Vaccine Immunol Date: 2016-08-05